YAN QIN LIU
Massage Therapy in Ann Arbor, MI
License number
Michigan 7501003257
Issued Date
Jun 13, 2014
Expiration Date
Oct 31, 2015
Category
Massage Therapist
Type
Massage Therapist
Address
Address
Ann Arbor, MI 48105
Personal information
See more information about YAN QIN LIU at radaris.comName
Address
Phone
512 W Fairmount Ave, Pontiac, MI 48340
5296 Falmouth Dr, Troy, MI 48085
Professional information
See more information about YAN QIN LIU at trustoria.com
Materials And Methods For Foxp3 Tumor Suppression
Materials And Methods For Foxp3 Tumor Suppression
US Patent:
8158596, Apr 17, 2012
Filed:
May 12, 2008
Appl. No.:
12/119158
Inventors:
Yang Liu - Ann Arbor MI, US
Pan Zheng - Ann Arbor MI, US
Xing Chang - Ann Arbor MI, US
Lizhong Wang - Ann Arbor MI, US
Runhua Liu - Ann Arbor MI, US
Yin Wang - Ann Arbor MI, US
Yan Liu - Ann Arbor MI, US
Tao Zuo - Columbus OH, US
Pan Zheng - Ann Arbor MI, US
Xing Chang - Ann Arbor MI, US
Lizhong Wang - Ann Arbor MI, US
Runhua Liu - Ann Arbor MI, US
Yin Wang - Ann Arbor MI, US
Yan Liu - Ann Arbor MI, US
Tao Zuo - Columbus OH, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 48/00, A01N 63/00
US Classification:
514 44R, 424 931
Abstract:
Provided herein are methods of treating a cancer in a subject comprising administering a FOXP3 protein, a nucleic acid encoding a FOXP3 protein, or an inducing compound which induces FOXP3 protein expression. Methods of altering a phenotype of a cancer cell or tumor cell, methods of inhibiting growth of such cells, and methods of inducing apoptosis of these cells are also provided herein. These methods comprise contacting the cell with a FOXP3 protein, a nucleic acid encoding a FOXP3 protein, or an inducing compound which induces FOXP3 protein expression. Further provided herein are diagnostic methods, comprising comparing the expression or structure of a FOXP3 protein or FOXP3 gene in a test sample to that of a normal or prior sample. A method of screening a test compound for anti-cancer activity comprising administering to cells the test compound and measuring FOXP3 protein or FOXP3 gene expression is moreover provided herein.
Uses Of Hypoxia-Inducible Factor Inhibitors
Uses Of Hypoxia-Inducible Factor Inhibitors
US Patent:
2012026, Oct 18, 2012
Filed:
Jun 25, 2010
Appl. No.:
13/513659
Inventors:
Yang Liu - Ann Arbor MI, US
Yin Wang - Ann Arbor MI, US
Yan Liu - Ann Arbor MI, US
Sami N. Malek - Ann Arbor MI, US
Pan Zheng - Ann Arbor MI, US
Yin Wang - Ann Arbor MI, US
Yan Liu - Ann Arbor MI, US
Sami N. Malek - Ann Arbor MI, US
Pan Zheng - Ann Arbor MI, US
Assignee:
ONCOIMMUNE INC. - Ann Arbor MI
International Classification:
A61K 38/12, A61P 35/00
US Classification:
514 196, 514 199
Abstract:
The present invention relates to treating a hematologic cancer using a Hypoxia- Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.